SCHEMBL22015596

SCHEMBL22015596

CCc1ccc(S(N)(=O)=O)c(C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDIA6 Q15084 1/20 0.53
CA2 P00918 6/20 0.52
TRPA1 O75762 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PDE2A O00408 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
PKM P14618 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
CA1 P00915 2/20 0.37
CA12 O43570 1/20 0.37
CA6 P23280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8405351 0.85 PDIA6 (0.53) PDIA6CA2L3MBTL1ALDH1A1KDM4E
SCHEMBL1807162 0.85 PDIA6 (0.53) PDIA6CA2L3MBTL1ALDH1A1KDM4E
SCHEMBL7904621 0.85 CA2 (0.52) PDIA6CA2TRPA1ALDH1A1MEN1
SCHEMBL29469901 0.85 CA2 (0.52) PDIA6CA2TRPA1ALDH1A1MEN1
SCHEMBL4139997 0.84 L3MBTL1 (0.41) PDIA6CA2TRPA1L3MBTL1ALDH1A1
SCHEMBL1807165 0.83 PDIA6 (0.51) PDIA6CA2L3MBTL1ALDH1A1KDM4E
SCHEMBL9174184 0.82 CA2 (0.53) PDIA6CA2TRPA1L3MBTL1ALDH1A1
SCHEMBL17922517 0.82 L3MBTL1 (0.55) CA2TRPA1L3MBTL1ALDH1A1MEN1
SCHEMBL1805243 0.81 PDIA6 (0.50) PDIA6CA2L3MBTL1ALDH1A1KDM4E
SCHEMBL1607447 0.81 ESR2 (0.41) CA2TRPA1L3MBTL1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102574-A1 THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed